Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Traws Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 30 | −1 |
| Shares | 1.79M | 132 | 1.75M | −38.3K (−2.1%) |
| Value | $2.36M | $0 | $1.54M | −$820.6K (−34.8%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Traws Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna Fundamental Investments, LLC | 33,900 | $30.0K | 0.00% |
| Virtu Financial LLC | 23,442 | $21.0K | 0.00% |
| Edmond de Rothschild Holding S.A. | 6,666 | $6.00K | 0.00% |
Sold out (4)
Institutions that held Traws Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Jane Street Group, LLC | 14,977 | $20.0K |
| Susquehanna International Group, LLP | 13,356 | $18.0K |
| Citigroup Inc | 135 | $0 |
| Northwestern Mutual Wealth Management Co | 33 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Traws Pharma, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Cordasco Financial Network | 132 | $0 |